Untitled

Download a copy of this content.

HealthTrust presents…“TenectePLACE in Acute Stroke Management”

Acute ischemic stroke (AIS) is the leading cause of lifelong disability affecting about 700,000 patients annually. Goals of AIS treatment include minimizing neurologic injury by reducing clot burden and restoring adequate blood flow to the brain to reduce the likelihood of lifelong disability. Current standard of care includes treatment with intravenous fibrinolytic therapy and/or mechanical thrombectomy. Currently, recombinant tissue plasminogen activator (tPA) is the FDA approved treatment of choice for AIS. The AHA/ASA AIS treatment guidelines additionally recommend tenecteplase, another fibrinolytic agent, as an alternative treatment option to tPA. The presenter will review emerging literature that supports tenecteplase use for AIS and potential risks and benefits of using tenecteplase over tPA.

Learning Objectives | At the end of this session, participants should be able to…

1. Explain the differences between recombinant tissue plasminogen activator (tPA) and tenecteplase
2. Describe current practice guidelines for acute ischemic stroke
3. Explain current literature for the use of tenecteplase in the setting of acute ischemic stroke

Presenter:

Jessica Laub, PharmD, Registered Pharmacist   |  PGY-2 Emergency Medicine Pharmacy Resident  |  Ernest Mario School of Pharmacy

Target Audience: Pharmacists & Nurses

Continuing Education Information: 1.0 contact hour approved for Nurses and Pharmacists. Belmont University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  The ACPE Universal Activity Number for this activity is 0863-9999-20-056-L01-P. The activity is approved for 1 hour (.1 CEUs) of continuing education credit for Nurses and Pharmacists who attend the webinar and complete the online evaluation.

California Board of Registered Nursing Approval. Pfiedler is a provider approved by the California Board of Registered Nursing, Provider Number CEP 14944 for 1.0 contact hour.

Note about CE credit: If you plan to obtain credit, stay until the end of the presentation to receive the verification code you will need to obtain your continuing education credit. A reminder that CE credit is individual. No group credit is available. Each person must register for this session and attend the entire webinar in order to receive an email after the event with instructions on how to apply for continuing education credit. Please do not share the code or forward the email you receive to others who did not actually attend the program. If they are not able to be verified on our webinar provider reports and registration list they will not receive credit. Also, please note: If you are joining only by phone, you will not be eligible for credit. You must also log in and join the visual portion of the webinar to be part of our CE provider-required reporting.

Effective June 1, 2019: Belmont College of Pharmacy will no longer issue paper/electronic statements of credit for CE activities. ACPE (our accrediting body) policy states paper and/or electronic statements of credit may no longer be distributed directly to learners as proof of ACPE credit. The official record of credit may be located in the learner’s e-profile in CPE Monitor at www.nabp.net.  A participant, sponsor, faculty member or other individual wanting to file a grievance with respect to any aspect of a program sponsored or co-sponsored by the Belmont COP may contact the Dean of Belmont University College of Pharmacy in writing at david.gregory@belmont.edu. The grievance will be reviewed and a response will be returned within 45 days of receiving the written statement. If not satisfied, an appeal to the Dean of the College of Pharmacy can be made for a second level of review.